Healthy Adult Participants clinical trials

Explore recruiting healthy adult participants clinical trials.

Recruiting healthy adult participants studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Healthy Adult Participants trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A study in healthy volunteers to find out how long aticaprant stays in and acts on the body when administered with or without rabeprazole.

Belgium

Human Pharmacology (Phase I)- Other EU CTIS Study details

An Open-label, Single-dose, Parallel-group Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Aticaprant (JNJ-67953964)

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

An Open-Label, Single-Center, Single-Dose Study to Assess the Absolute Oral Bioavailability and Pharmacokinetics of Aticaprant Administered as an Oral Tablet and an Intravenous Infusion Microdose of 14C-Aticaprant in Healthy Participants

Belgium

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Randomised, Placebo-Controlled, Double-Blind, Single-Ascending Dose and Multiple-Ascending Dose First-In-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orally Administered ALE1 With or Without Food in Healthy Adult Participants and Adult Patients With Hypophosphatasia

Germany

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A study in healthy volunteers to find out how long aticaprant stays in and acts on the body when administered with or without food and with or without fluconazole

Belgium

Human Pharmacology (Phase I)- Other EU CTIS Study details

An Open-label, Single-dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of Aticaprant (JNJ-67953964)

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Healthy Adult Participants trials by city

Healthy Adult Participants in Toronto Healthy Adult Participants in Vancouver Healthy Adult Participants in Montreal Healthy Adult Participants in Calgary Healthy Adult Participants in Edmonton Healthy Adult Participants in Ottawa Healthy Adult Participants in Winnipeg Healthy Adult Participants in Quebec City Healthy Adult Participants in Hamilton Healthy Adult Participants in Kitchener Healthy Adult Participants in London Healthy Adult Participants in Halifax Healthy Adult Participants in New York Healthy Adult Participants in Los Angeles Healthy Adult Participants in Chicago Healthy Adult Participants in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease